DataMeds AI, Inc. - Common Stock (NQ:MEDS)

2.850 -0.220 (-7.15%)

Delayed Quote Updated: 1:07 PM EDT, Oct 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about DataMeds AI, Inc. - Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

InvestorNewsBreaks – TRxADE Health Inc.’s (NASDAQ: MEDS) Bonum Health(TM) to Work with Insurance Brokers to Offer Telemedicine Services for SMB Employer Groups

October 26, 2022

Via Investor Brand Network

12 Consumer Discretionary Stocks Moving In Tuesday's After-Market Session ↗

October 25, 2022

Gainers Group 1 Automotive (NYSE:GPI) shares rose 15.4% to $188.0 during Tuesday's after-market session. The market value of their outstanding shares is at $2.9 billion.

Via Benzinga

InvestorNewsBreaks – Trxade Health Inc. (NASDAQ: MEDS) Announces Call to Discuss Upcoming 3Q Financial Results

October 25, 2022

Via Investor Brand Network

Bonum Health™, LLC (a TRxADE HEALTH Company) Strikes Strategic Business-to-Business (B2B) Telemedicine Services Agreement with Insurance Brokerage Firm(s) for Small-to-Medium Business (SMB) Employer Groups

October 25, 2022

From Trxade Health, Inc.

Via GlobeNewswire

TRxADE HEALTH, INC. to Report Third Quarter 2022 Financial Results on Monday, November 7th at 5:00 p.m. Eastern Time

October 24, 2022

Via ACCESSWIRE

InvestorNewsBreaks – Trxade Health Inc. (NASDAQ: MEDS) Enters into $1.8M Registered Direct Offering

October 05, 2022

Via Investor Brand Network

121 Stocks That Hit Their 52-Week Low ↗

October 14, 2022

New Equities that Broke Through 52-Week Lows Friday Morning During Friday's morning session, 121 stocks hit new 52-week lows.

Via Benzinga

TRxADE Health Announces Pricing of $1.8 Million Registered Direct Offering

October 04, 2022

Via ACCESSWIRE

InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Announces Board Appointment of Leading Pharmaceutical Industry Expert

October 03, 2022

Via Investor Brand Network

TRxADE HEALTH, INC. Taps Advisory Board Member and Leading Pharmaceutical Industry Expert, Mr. Jeff Newell, For its Board of Directors

October 03, 2022

From Trxade Health, Inc.

Via GlobeNewswire

12 Consumer Discretionary Stocks Moving In Thursday's Pre-Market Session ↗

September 22, 2022

Gainers China Liberal Education (NASDAQ:CLEU) stock rose 9.3% to $0.95 during Thursday's pre-market session. The market value of their outstanding shares is at $15.0 million.

Via Benzinga

Why Stabilis Solutions Shares Jumped Over 71%; Here Are 70 Biggest Movers From Yesterday ↗

September 22, 2022

Gainers

Via Benzinga

Why Adamis Pharmaceuticals Is Trading Lower By Around 44%, Here Are 46 Stocks Moving In Wednesday's Mid-Day Session ↗

September 21, 2022

Gainers

Via Benzinga

12 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session ↗

September 21, 2022

Gainers Greenlane Hldgs (NASDAQ:GNLN) stock rose 6.8% to $2.04 during Wednesday's pre-market session. The market value of their outstanding shares is at $15.0 million.

Via Benzinga

TRxADE Health (NASDAQ: MEDS) Subsidiary, Bonum Health Enters into Telehealth Services Deal with Wakefern Food Corp.

September 20, 2022

TRxADE Health, Inc. (NASDAQ: MEDS) is engaged as a health services IT company, which is focused on digitalizing the entire

Via Spotlight Growth

Why SOBR Safe Shares Surged Around 233%; Here Are 68 Biggest Movers From Yesterday ↗

September 21, 2022

Gainers

Via Benzinga

Dow Dips 400 Points; Ford Shares Slide ↗

September 20, 2022

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping 400 points on Tuesday.

Via Benzinga

11 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session ↗

September 20, 2022

Via Benzinga

Why Virios Therapeutics Is Trading Lower By 75%, Here Are 44 Stocks Moving In Tuesday's Mid-Day Session ↗

September 20, 2022

Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares jumped 51% to $0.4957. Crown ElectroKinetics, last month, posted a Q4 net loss of $4.5 million.

Via Benzinga

How Is The Market Feeling About Trxade Health? ↗

September 20, 2022

Trxade Health's (NASDAQ:MEDS) short percent of float has risen 195.48% since its last report. The company recently reported that it has 176 thousand shares sold short, which is 4....

Via Benzinga

Nasdaq Down 50 Points; Crude Oil Falls Sharply ↗

September 20, 2022

U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping around 50 points on Tuesday.

Via Benzinga

Wakefern Food Corp. and Bonum Health(TM), LLC (a TRxADE HEALTH Company) Ink a Telemedicine Services Deal

September 20, 2022

Via ACCESSWIRE

InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Launches TRxADE Prime Plus to Meet Customers’ Needs of On-Demand Inventory

August 30, 2022

Via Investor Brand Network

Topics Supply Chain

12 Consumer Discretionary Stocks Moving In Monday's Pre-Market Session ↗

August 29, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

August 29, 2022

We're breaking down the biggest pre-market stock movers and the news that has them rising and falling for Monday morning!

Via InvestorPlace

Why Everbridge Jumped Over 17%; Here Are 90 Biggest Movers From Friday ↗

August 29, 2022

Gainers Micro Focus International plc (NYSE: MFGP) shares surged 92% to close at $6.01 on Friday after the company reached an agreement with OpenText to be acquired for $6 billion.

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

August 25, 2022

On Thursday, 63 companies set new 52-week lows.

Via Benzinga

12 Consumer Discretionary Stocks Moving In Wednesday's Intraday Session ↗

August 24, 2022

Via Benzinga

Why Minerva Neurosciences Shares Traded Higher By Over 66%; Here Are 78 Biggest Movers From Yesterday ↗

August 25, 2022

Gainers Minerva Neurosciences, Inc. (NASDAQ: NERV) shares gained 66.5% to close at $7.51 after Point72 Asset Management reported an 8.8% passive stake in the company.

Via Benzinga

Why Citi Trends Is Trading Lower By 17%, Here Are 47 Stocks Moving In Wednesday's Mid-Day Session ↗

August 24, 2022

Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares jumped 77% to $2.35. Bright Minds priced overnight marketed offering of 2.858 million units at $1.40 per unit.

Via Benzinga

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.